UC San Diego Health Sciences schools, institutes and centers are at the forefront of discovery and transformation.
Researchers from UC San Diego have found that high-nicotine e-cigarette use rose sharply among young adults between 2017 and 2022 and was associated with increased nicotine dependence and more persistent vaping.
A new forecasting feature in the County's respiratory report shows flu activity rising unusually early.
In landmark single-cell study of pancreatic tumors, UC San Diego Moores Cancer Center researchers reveal how tumor evolution shapes disease, which could yield new, more effective treatments for one of the deadliest cancers.
A new PRIME program at UC San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences will train the next generation of pharmacy leaders to work in underserved areas.
InflammaSense’s wearable VITALx-patch sensor will monitor patients’ immune responses in real time as part of a federal initiative.
UC San Diego has retained its title as the No. 1 public research university in the nation, according to Washington Monthly's 2026 College Guide and Rankings “America’s Best Colleges for Research.” It also retained its No. 6 ranking among all research universities in the U.S.
Gizmodo, October 27
Sci Tech Daily, October 22
Becker's Hospital Review, October 22
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
